Immunological induction with thymoglobulin: reduction in the number of doses in renal transplant from deceased donor.

about

Immunological induction with thymoglobulin: reduction in the number of doses in renal transplant from deceased donor.

Item

http://www.wikidata.org/entity/Q53265118

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Immunological induction with t ...... ransplant from deceased donor.

@en

Immunological induction with t ...... ransplant from deceased donor.

@nl

type

Item

label

Immunological induction with t ...... ransplant from deceased donor.

@en

Immunological induction with t ...... ransplant from deceased donor.

@nl

prefLabel

Immunological induction with t ...... ransplant from deceased donor.

@en

Immunological induction with t ...... ransplant from deceased donor.

@nl

P1476

Immunological induction with t ...... ransplant from deceased donor.

@en

P2093

Alvaro Pacheco-Silva

http://www.w3.org/2001/XMLSchema#string

Ana Cristina Carvalho Matos

http://www.w3.org/2001/XMLSchema#string

Eduardo José Tonato

http://www.w3.org/2001/XMLSchema#string

Lucio Roberto Requião Moura

http://www.w3.org/2001/XMLSchema#string

Marcelino de Souza Durão

http://www.w3.org/2001/XMLSchema#string

Maurício Rodrigues Fregonesi da Silva

http://www.w3.org/2001/XMLSchema#string

Rogério Chinen

http://www.w3.org/2001/XMLSchema#string

Thiago Corsi Filliponi

http://www.w3.org/2001/XMLSchema#string

Érika Arruda Ferraz

http://www.w3.org/2001/XMLSchema#string

P2860

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.

Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure.

The economic burden of end-stage renal disease in Canada.

The clinical use of antilymphocyte globulin in renal homotransplantation

Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.

Low toxicity regimens in renal transplantation: a country subset analysis of the Symphony study.

Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.

Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients.

Protective effect of T cell depletion in murine renal ischemia-reperfusion injury.

P304

56-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S1679-45082011AO1838

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26760554

http://www.w3.org/2001/XMLSchema#string

P921

immunology